BioMarin Pharmaceutical - 25 Year Stock Price History | BMRN

Historical daily share price chart and data for BioMarin Pharmaceutical since 1999 adjusted for splits and dividends. The latest closing stock price for BioMarin Pharmaceutical as of April 17, 2024 is 90.47.
  • The all-time high BioMarin Pharmaceutical stock closing price was 149.13 on July 20, 2015.
  • The BioMarin Pharmaceutical 52-week high stock price is 99.56, which is 10% above the current share price.
  • The BioMarin Pharmaceutical 52-week low stock price is 76.02, which is 16% below the current share price.
  • The average BioMarin Pharmaceutical stock price for the last 52 weeks is 89.79.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
BioMarin Pharmaceutical Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 89.4373 98.0500 99.0000 83.8100 90.4700 -6.17%
2023 93.7643 100.6100 117.2700 76.2200 96.4200 -6.83%
2022 86.6013 89.3600 108.6300 71.4800 103.4900 17.14%
2021 80.5858 86.3000 91.4700 71.7200 88.3500 0.75%
2020 91.5134 84.0400 131.0300 71.3700 87.6900 3.71%
2019 82.5653 84.9600 98.6200 64.2700 84.5500 -0.70%
2018 92.1163 91.0300 106.0700 76.0100 85.1500 -4.51%
2017 88.8143 85.8400 98.8200 80.6000 89.1700 7.64%
2016 86.6998 104.9200 104.9200 64.7400 82.8400 -20.92%
2015 117.0456 92.1700 149.1300 90.2800 104.7600 15.88%
2014 70.7528 69.2700 94.1900 55.7800 90.4000 28.50%
2013 63.4324 51.9200 78.3880 51.5600 70.3500 42.99%
2012 39.1417 34.9300 50.1700 32.1300 49.2000 43.11%
2011 28.4184 26.6100 35.3800 23.4600 34.3800 27.66%
2010 22.1536 18.9500 28.2500 18.2400 26.9300 43.17%
2009 15.6685 17.6500 20.8300 10.1400 18.8100 5.67%
2008 29.7800 36.6400 40.3900 13.5900 17.8000 -49.72%
2007 21.0564 16.1000 36.5800 15.7100 35.4000 115.99%
2006 14.3090 10.9900 18.0400 10.9600 16.3900 52.04%
2005 7.3643 6.2600 11.4100 4.4300 10.7800 68.70%
2004 6.2104 7.9100 8.7900 3.8700 6.3900 -17.65%
2003 9.4406 7.0300 13.3200 6.4100 7.7600 10.07%
2002 7.2827 13.2400 13.9500 3.6500 7.0500 -47.54%
2001 11.0435 9.5000 14.1600 7.3130 13.4400 38.73%
2000 18.0555 12.7500 38.7500 7.1560 9.6880 -17.55%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $17.150B $2.419B
BioMarin Pharmaceutical Inc. focuses on the development and commercialization of treatments for serious life-threatening medical conditions, mostly for children. The company's portfolio comprises seven marketed products namely, Aldurazyme, Naglazyme, Kuvan a rare genetic enzyme deficiency disorder), Vimizim , Brineura, Palynziq and Voxzogo. BioMarin has a collaboration agreement with Sanofi's subsidiary Genzyme for Aldurazyme. Genzyme is BioMarin's sole customer for Aldurazyme and is responsible for marketing and selling Aldurazyme to third parties.?The newest drug in BioMarin's portfolio, Voxzogo for treating achondroplasia, the most common form of dwarfism. BioMarin's biologics license application (BLA) for Roctavian/valoctocogene roxaparvovec (valrox), a gene therapy for severe hemophilia A, was given a complete response letter (CRL) by the FDA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $142.362B 14.24
Vertex Pharmaceuticals (VRTX) United States $101.877B 29.33
Regeneron Pharmaceuticals (REGN) United States $98.143B 23.79
Bristol Myers Squibb (BMY) United States $97.811B 6.43
CSL (CSLLY) Australia $84.888B 0.00
Gilead Sciences (GILD) United States $83.806B 10.02
GSK (GSK) United Kingdom $82.794B 10.38
Moderna (MRNA) United States $39.739B 0.00
Biogen (BIIB) United States $28.367B 13.25
Argenex SE (ARGX) Netherlands $21.982B 0.00
BioNTech SE (BNTX) Germany $20.525B 20.96
Genmab (GMAB) Denmark $19.460B 24.94
Illumina (ILMN) United States $18.743B 135.28
Alnylam Pharmaceuticals (ALNY) United States $18.479B 0.00
BeiGene (BGNE) Cayman Islands $12.821B 0.00
Incyte (INCY) United States $11.949B 19.86
Exact Sciences (EXAS) United States $11.593B 0.00
Sarepta Therapeutics (SRPT) United States $11.014B 0.00
Bio-Techne Corp (TECH) United States $10.062B 37.43
Bio-Rad Laboratories (BIO.B) United States $9.655B 28.76
Repligen (RGEN) United States $9.167B 94.90
Legend Biotech (LEGN) United States $9.117B 0.00
QIAGEN (QGEN) Netherlands $8.973B 18.57
Roivant Sciences (ROIV) United Kingdom $8.631B 0.00
Ascendis Pharma (ASND) Denmark $8.239B 0.00
Intra-Cellular Therapies (ITCI) United States $7.729B 0.00
Viking Therapeutics (VKTX) United States $7.489B 0.00
Cytokinetics (CYTK) United States $7.216B 0.00
Exelixis (EXEL) United States $6.919B 35.66
Vaxcyte (PCVX) United States $6.769B 0.00
Apellis Pharmaceuticals (APLS) United States $6.249B 0.00
Blueprint Medicines (BPMC) United States $5.269B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.920B 0.00
Halozyme Therapeutics (HALO) United States $4.876B 15.05
Krystal Biotech (KRYS) United States $4.850B 0.00
Zealand Pharma (ZLDPF) Denmark $4.430B 0.00
Immunovant (IMVT) United States $4.417B 0.00
Nuvalent (NUVL) United States $4.148B 0.00
Alkermes (ALKS) Ireland $4.022B 21.22
Insmed (INSM) United States $3.885B 0.00
Biohaven (BHVN) United States $3.571B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.482B 0.00
ImmunityBio (IBRX) United States $3.331B 0.00
Iovance Biotherapeutics (IOVA) United States $3.329B 0.00
Fortrea Holdings (FTRE) United States $3.290B 0.00
Axsome Therapeutics (AXSM) United States $3.260B 0.00
SpringWorks Therapeutics (SWTX) United States $3.202B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.130B 0.00
Amicus Therapeutics (FOLD) United States $3.119B 0.00
IDEAYA Biosciences (IDYA) United States $3.070B 0.00
Apogee Therapeutics (APGE) United States $2.961B 0.00
Arcellx (ACLX) United States $2.943B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.907B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.814B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.779B 0.00
Certara (CERT) United States $2.734B 58.86
MorphoSys AG (MOR) Germany $2.704B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.659B 0.00
Janux Therapeutics (JANX) United States $2.611B 0.00
CG Oncology (CGON) United States $2.430B 0.00
Denali Therapeutics (DNLI) United States $2.413B 0.00
Merus (MRUS) Netherlands $2.366B 0.00
Vera Therapeutics (VERA) United States $2.318B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.317B 0.00
Vericel (VCEL) United States $2.299B 0.00
Arvinas (ARVN) United States $2.277B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.195B 0.00
Celldex Therapeutics (CLDX) United States $2.158B 0.00
Beam Therapeutics (BEAM) United States $2.099B 0.00
Intellia Therapeutics (NTLA) United States $2.096B 0.00
Keros Therapeutics (KROS) United States $2.087B 0.00
Kymera Therapeutics (KYMR) United States $2.074B 0.00
Guardant Health (GH) United States $1.967B 0.00
Ginkgo Bioworks Holdings (DNA) United States $1.966B 0.00
Geron (GERN) United States $1.958B 0.00
Galapagos (GLPG) Belgium $1.943B 0.00
Avidity Biosciences (RNA) United States $1.906B 0.00
Sana Biotechnology (SANA) United States $1.854B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.808B 0.00
NeoGenomics (NEO) United States $1.768B 0.00
Structure Therapeutics (GPCR) United States $1.762B 0.00
Neumora Therapeutics (NMRA) United States $1.741B 0.00
Myriad Genetics (MYGN) United States $1.700B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.691B 14.05
Bavarian Nordic (BVNRY) Denmark $1.673B 5.49
Twist Bioscience (TWST) United States $1.654B 0.00
Inhibrx (INBX) United States $1.640B 0.00
Edgewise Therapeutics (EWTX) United States $1.548B 0.00
Protagonist Therapeutics (PTGX) United States $1.522B 0.00
Dynavax Technologies (DVAX) United States $1.504B 0.00
Arcus Biosciences (RCUS) United States $1.442B 0.00
Zai Lab (ZLAB) China $1.431B 0.00
Kura Oncology (KURA) United States $1.416B 0.00
Ligand Pharmaceuticals (LGND) United States $1.415B 17.53
ADMA Biologics Inc (ADMA) United States $1.406B 0.00
Morphic Holding (MORF) United States $1.394B 0.00
ANI Pharmaceuticals (ANIP) United States $1.382B 16.98
Gyre Therapeutics (GYRE) United States $1.367B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.309B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.292B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.277B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.233B 0.00
Akero Therapeutics (AKRO) United States $1.227B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.199B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.194B 0.00
AbCellera Biologics (ABCL) Canada $1.186B 0.00
Prothena (PRTA) Ireland $1.146B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.129B 0.00
Vir Biotechnology (VIR) United States $1.124B 0.00
Immunome (IMNM) United States $1.098B 0.00
MannKind (MNKD) United States $1.096B 0.00
Scholar Rock Holding (SRRK) United States $1.090B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $1.088B 0.00
Belite Bio (BLTE) United States $1.046B 0.00
Liquidia Technologies (LQDA) United States $1.032B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.024B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.978B 0.00
Kyverna Therapeutics (KYTX) United States $0.967B 0.00
Viridian Therapeutics (VRDN) United States $0.947B 0.00
Abivax SA (ABVX) France $0.927B 0.00
MiMedx (MDXG) United States $0.916B 207.67
Zentalis Pharmaceuticals (ZNTL) United States $0.914B 0.00
Immatics (IMTX) Germany $0.879B 0.00
89BIO (ETNB) United States $0.876B 0.00
REGENXBIO (RGNX) United States $0.858B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.811B 0.00
Pliant Therapeutics (PLRX) United States $0.799B 0.00
CARGO Therapeutics (CRGX) United States $0.787B 0.00
Cabaletta Bio (CABA) United States $0.786B 0.00
Tango Therapeutics (TNGX) United States $0.784B 0.00
Cytek Biosciences (CTKB) United States $0.781B 0.00
Tyra Biosciences (TYRA) United States $0.770B 0.00
Cullinan Oncology (CGEM) United States $0.746B 0.00
ALX Oncology Holdings (ALXO) United States $0.727B 0.00
Disc Medicine (IRON) United States $0.723B 0.00
Nurix Therapeutics (NRIX) United States $0.720B 0.00
Dianthus Therapeutics (DNTH) United States $0.708B 0.00
Pharming Group (PHGUF) Netherlands $0.695B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.694B 0.00
Praxis Precision Medicines (PRAX) United States $0.694B 0.00
PureTech Health (PRTC) United States $0.688B 0.00
Pharming Group (PHAR) Netherlands $0.682B 0.00
EnGene Holdings (ENGN) United States $0.680B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.663B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.659B 0.00
Aerovate Therapeutics (AVTE) United States $0.658B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.657B 0.00
HilleVax (HLVX) United States $0.647B 0.00
WAVE Life Sciences (WVE) Singapore $0.643B 0.00
Oric Pharmaceuticals (ORIC) United States $0.637B 0.00
Prime Medicine (PRME) United States $0.632B 0.00
Zymeworks (ZYME) United States $0.630B 0.00
Cogent Biosciences (COGT) United States $0.618B 0.00
Nuvation Bio (NUVB) United States $0.613B 0.00
Astria Therapeutics (ATXS) United States $0.609B 0.00
Northwest Biotherapeutics (NWBO) United States $0.608B 0.00
Absci (ABSI) United States $0.607B 0.00
Olema Pharmaceuticals (OLMA) United States $0.605B 0.00
Mineralys Therapeutics (MLYS) United States $0.599B 0.00
CureVac (CVAC) Germany $0.597B 0.00
Allogene Therapeutics (ALLO) United States $0.592B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.587B 0.00
Stoke Therapeutics (STOK) United States $0.576B 0.00
GH Research (GHRS) Ireland $0.572B 0.00
AnaptysBio (ANAB) United States $0.571B 0.00
ArriVent BioPharma (AVBP) United States $0.563B 0.00
Novavax (NVAX) United States $0.558B 0.00
Applied Therapeutics (APLT) United States $0.545B 0.00
IGM Biosciences (IGMS) United States $0.541B 0.00
Mesoblast (MESO) Australia $0.535B 0.00
Fate Therapeutics (FATE) United States $0.534B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.527B 0.00
Celcuity (CELC) United States $0.525B 0.00
Arbutus Biopharma (ABUS) United States $0.524B 0.00
Castle Biosciences (CSTL) United States $0.520B 0.00
Alector (ALEC) United States $0.508B 0.00
ACELYRIN, INC (SLRN) United States $0.506B 0.00
Oculis Holding AG (OCS) Switzerland $0.486B 0.00
Editas Medicine (EDIT) United States $0.479B 0.00
Third Harmonic Bio (THRD) United States $0.472B 0.00
C4 Therapeutics (CCCC) United States $0.469B 0.00
Travere Therapeutics (TVTX) United States $0.468B 0.00
Annexon (ANNX) United States $0.460B 0.00
Fulcrum Therapeutics (FULC) United States $0.459B 0.00
Avid Bioservices (CDMO) United States $0.458B 0.00
Mersana Therapeutics (MRSN) United States $0.456B 0.00
Neurogene (NGNE) United States $0.452B 0.00
Replimune (REPL) United States $0.439B 0.00
Voyager Therapeutics (VYGR) United States $0.433B 2.58
Biomea Fusion (BMEA) United States $0.429B 0.00
Entrada Therapeutics (TRDA) United States $0.427B 0.00
Shattuck Labs (STTK) United States $0.426B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.417B 0.00
MaxCyte (MXCT) United States $0.417B 0.00
Ocugen (OCGN) United States $0.408B 0.00
PepGen (PEPG) United States $0.407B 0.00
Adaptive Biotechnologies (ADPT) United States $0.399B 0.00
ITeos Therapeutics (ITOS) United States $0.398B 0.00
Revance Therapeutics (RVNC) United States $0.397B 0.00
Adlai Nortye (ANL) Cayman Islands $0.389B 0.00
Nkarta (NKTX) United States $0.385B 0.00
Anika Therapeutics (ANIK) United States $0.379B 0.00
Solid Biosciences (SLDB) United States $0.372B 0.00
Amarin (AMRN) Ireland $0.368B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.366B 0.00
Alto Neuroscience (ANRO) United States $0.365B 0.00
Humacyte (HUMA) United States $0.364B 0.00
Jasper Therapeutics (JSPR) United States $0.364B 0.00
Caribou Biosciences (CRBU) United States $0.362B 0.00
Aura Biosciences (AURA) United States $0.359B 0.00
FibroBiologics (FBLG) United States $0.359B 0.00
Tenaya Therapeutics (TNYA) United States $0.350B 0.00
MeiraGTx Holdings (MGTX) United States $0.347B 0.00
Rani Therapeutics Holdings (RANI) United States $0.345B 0.00
TScan Therapeutics (TCRX) United States $0.341B 0.00
Urogen Pharma (URGN) United States $0.340B 0.00
Precigen (PGEN) United States $0.339B 0.00
Anavex Life Sciences (AVXL) United States $0.338B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.336B 0.00
Ventyx Biosciences (VTYX) United States $0.336B 0.00
Invivyd (IVVD) United States $0.322B 0.00
Nautilus Biotechnology (NAUT) United States $0.315B 0.00
Atea Pharmaceuticals (AVIR) United States $0.315B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.304B 0.00
Terns Pharmaceuticals (TERN) United States $0.302B 0.00
Inozyme Pharma (INZY) United States $0.300B 0.00
ChromaDex (CDXC) United States $0.297B 0.00
CorMedix Inc (CRMD) United States $0.297B 0.00
Erasca (ERAS) United States $0.292B 0.00
Contineum Therapeutics (CTNM) United States $0.284B 0.00
XOMA (XOMA) United States $0.284B 0.00
Rapt Therapeutics (RAPT) United States $0.283B 0.00
Kamada (KMDA) Israel $0.282B 21.30
Verastem (VSTM) United States $0.277B 0.00
XBiotech (XBIT) United States $0.273B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.252B 0.00
2seventy Bio (TSVT) United States $0.249B 0.00
Sutro Biopharma (STRO) United States $0.246B 0.00
Puma Biotechnology (PBYI) United States $0.246B 11.09
Coherus BioSciences (CHRS) United States $0.244B 0.00
Werewolf Therapeutics (HOWL) United States $0.243B 0.00
AC Immune (ACIU) Switzerland $0.242B 0.00
Adverum Biotechnologies (ADVM) United States $0.241B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.233B 81.00
Inovio Pharmaceuticals (INO) United States $0.225B 0.00
UniQure (QURE) Netherlands $0.225B 0.00
Ovid Therapeutics (OVID) United States $0.224B 0.00
X4 Pharmaceuticals (XFOR) United States $0.222B 0.00
Compass Therapeutics (CMPX) United States $0.216B 0.00
Elevation Oncology (ELEV) United States $0.214B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.213B 0.00
G1 Therapeutics (GTHX) United States $0.213B 0.00
Abeona Therapeutics (ABEO) United States $0.212B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.210B 0.00
Innate Pharma S.A (IPHA) France $0.209B 0.00
Design Therapeutics (DSGN) United States $0.208B 0.00
Opthea (OPT) Australia $0.207B 0.00
Cardiff Oncology (CRDF) United States $0.205B 0.00
Kodiak Sciences (KOD) United States $0.204B 0.00
Skye Bioscience (SKYE) United States $0.201B 0.00
Prima BioMed (IMMP) Australia $0.199B 0.00
Lifecore Biomedical (LFCR) United States $0.198B 0.00
Poseida Therapeutics (PSTX) United States $0.196B 0.00
Akoya Biosciences (AKYA) United States $0.196B 0.00
Scilex Holding (SCLX) United States $0.193B 0.00
Codexis (CDXS) United States $0.192B 0.00
23andMe Holding (ME) United States $0.188B 0.00
Alimera Sciences (ALIM) United States $0.187B 0.00
Greenwich LifeSciences (GLSI) United States $0.186B 0.00
Gossamer Bio (GOSS) United States $0.185B 0.00
Trevi Therapeutics (TRVI) United States $0.184B 0.00
GENFIT S.A (GNFT) France $0.181B 0.00
Adicet Bio (ACET) United States $0.180B 0.00
Compugen (CGEN) Israel $0.176B 0.00
Inventiva S.A (IVA) France $0.174B 0.00
Candel Therapeutics (CADL) United States $0.173B 0.00
ScPharmaceuticals (SCPH) United States $0.168B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.167B 0.00
LENZ Therapeutics (LENZ) United States $0.166B 0.00
INmune Bio (INMB) United States $0.165B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.163B 0.00
Renovaro (RENB) United States $0.161B 0.00
BioStem Technologies (BSEM) $0.154B 0.00
CervoMed (CRVO) United States $0.153B 0.00
Syros Pharmaceuticals (SYRS) United States $0.149B 0.00
Spyre Therapeutics (SYRE) United States $0.147B 0.00
I-Mab (IMAB) China $0.144B 0.00
Molecular Partners AG (MOLN) Switzerland $0.142B 0.00
Cellectis S.A (CLLS) France $0.138B 0.00
Rezolute (RZLT) United States $0.136B 0.00
DBV Technologies S.A (DBVT) France $0.135B 0.00
Sagimet Biosciences (SGMT) United States $0.133B 0.00
Omega Therapeutics (OMGA) United States $0.133B 0.00
Agenus (AGEN) United States $0.132B 0.00
Zura Bio (ZURA) United States $0.131B 0.00
BioAtla (BCAB) United States $0.126B 0.00
CytomX Therapeutics (CTMX) United States $0.126B 0.00
VistaGen Therapeutics (VTGN) United States $0.126B 0.00
Nuvectis Pharma (NVCT) United States $0.124B 0.00
Repare Therapeutics (RPTX) Canada $0.124B 0.00
TELA Bio (TELA) United States $0.123B 0.00
Coya Therapeutics (COYA) United States $0.119B 0.00
Adagene (ADAG) China $0.119B 0.00
Vor Biopharma (VOR) $0.117B 0.00
Immunic (IMUX) United States $0.115B 0.00
Oncobiologics (OTLK) United States $0.114B 0.00
Seer (SEER) United States $0.113B 0.00
Vigil Neuroscience (VIGL) United States $0.112B 0.00
Annovis Bio (ANVS) United States $0.111B 0.00
ATyr Pharma (LIFE) United States $0.109B 0.00
Bluebird Bio (BLUE) United States $0.108B 0.00
Alpha Teknova (TKNO) United States $0.106B 0.00
PDS Biotechnology (PDSB) United States $0.103B 0.00
Emergent Biosolutions (EBS) United States $0.102B 0.00
Cartesian Therapeutics (RNAC) United States $0.101B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.101B 0.00
IO Biotech (IOBT) Denmark $0.099B 0.00
BioHarvest Sciences (CNVCF) Canada $0.099B 0.00
Elicio Therapeutics (ELTX) United States $0.099B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.098B 0.00
Sangamo Therapeutics (SGMO) United States $0.097B 0.00
Seres Therapeutics (MCRB) United States $0.096B 0.00
Connect Biopharma Holdings (CNTB) United States $0.095B 0.00
Genelux (GNLX) United States $0.095B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.094B 0.00
Allakos (ALLK) United States $0.092B 0.00
Curis (CRIS) United States $0.090B 0.00
DiaMedica Therapeutics (DMAC) United States $0.090B 0.00
Precision BioSciences (DTIL) United States $0.089B 0.00
Clearside Biomedical (CLSD) United States $0.086B 0.00
BioXcel Therapeutics (BTAI) United States $0.082B 0.00
Eton Pharmaceuticals (ETON) United States $0.082B 0.00
Affimed (AFMD) Germany $0.082B 0.00
Oncolytics Biotech (ONCY) Canada $0.081B 0.00
Atara Biotherapeutics (ATRA) United States $0.081B 0.00
Athira Pharma (ATHA) United States $0.081B 0.00
Q32 Bio (QTTB) United States $0.081B 0.00
HOOKIPA Pharma (HOOK) United States $0.080B 0.00
YS Biopharma (YS) China $0.079B 0.00
Spero Therapeutics (SPRO) United States $0.079B 2.94
InflaRx (IFRX) Germany $0.077B 0.00
Galena Biopharma (SLS) United States $0.077B 0.00
Passage Bio (PASG) United States $0.076B 0.00
Leap Therapeutics (LPTX) United States $0.076B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.076B 0.00
Gritstone Bio (GRTS) United States $0.076B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.075B 0.00
MediciNova (MNOV) United States $0.075B 0.00
Cognition Therapeutics (CGTX) United States $0.074B 0.00
AN2 Therapeutics (ANTX) United States $0.074B 0.00
Cue Biopharma (CUE) United States $0.073B 0.00
VTv Therapeutics (VTVT) United States $0.073B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.072B 0.00
Eupraxia Pharmaceuticals (EPRX) $0.071B 0.00
BeyondSpring (BYSI) United States $0.070B 0.00
Elutia (ELUT) United States $0.070B 0.00
Rallybio (RLYB) United States $0.068B 0.00
Immix Biopharma (IMMX) United States $0.068B 0.00
Celularity (CELU) United States $0.068B 0.00
Instil Bio (TIL) United States $0.067B 0.00
Landos Biopharma (LABP) United States $0.067B 0.00
Cidara Therapeutics (CDTX) United States $0.066B 0.00
Entera Bio (ENTX) Israel $0.066B 0.00
Kronos Bio (KRON) United States $0.066B 0.00
Equillium (EQ) United States $0.065B 0.00
Turnstone Biologics (TSBX) United States $0.065B 0.00
Lantern Pharma (LTRN) United States $0.064B 0.00
Aligos Therapeutics (ALGS) United States $0.063B 0.00
Genenta Science S.p.A (GNTA) Italy $0.063B 0.00
Ikena Oncology (IKNA) United States $0.061B 0.00
Ocean Biomedical (OCEA) United States $0.061B 0.00
Checkpoint Therapeutics (CKPT) United States $0.060B 0.00
HCW Biologics (HCWB) United States $0.060B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.059B 0.00
Enzo Biochem (ENZ) United States $0.059B 0.00
Kezar Life Sciences (KZR) United States $0.057B 0.00
AVROBIO (AVRO) United States $0.057B 0.00
Intensity Therapeutics (INTS) United States $0.056B 0.00
Vaxxinity (VAXX) United States $0.056B 0.00
Immuneering (IMRX) United States $0.054B 0.00
Dyadic (DYAI) United States $0.052B 0.00
Dare Bioscience (DARE) United States $0.049B 0.00
Apollomics (APLM) United States $0.048B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.048B 0.00
Beyond Air (XAIR) United States $0.048B 0.00
ARCA Biopharma (ABIO) United States $0.047B 0.00
Bionano Genomics (BNGO) United States $0.047B 0.00
CalciMedica (CALC) United States $0.047B 0.00
NextCure (NXTC) United States $0.046B 0.00
SAB Biotherapeutics (SABS) United States $0.045B 0.00
Xilio Therapeutics (XLO) United States $0.045B 0.00
Aadi Bioscience (AADI) United States $0.044B 0.00
Bolt Biotherapeutics (BOLT) United States $0.044B 0.00
Ocuphire Pharma (OCUP) United States $0.043B 0.00
Quince Therapeutics (QNCX) United States $0.043B 0.00
Carmell (CTCX) United States $0.042B 0.00
OKYO Pharma (OKYO) $0.042B 0.00
Clene (CLNN) United States $0.040B 0.00
Estrella Immunopharma (ESLA) United States $0.040B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.040B 0.00
Cara Therapeutics (CARA) United States $0.039B 0.00
Promis Neurosciences (PMN) Canada $0.038B 0.00
Semper Paratus Acquisition (TVGN) United States $0.037B 0.00
BRIACELL THERAP (BCTX) Canada $0.036B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.036B 0.00
Cyclo Therapeutics (CYTH) United States $0.035B 0.00
Fortress Biotech (FBIO) United States $0.034B 0.00
BioAffinity Technologies (BIAF) United States $0.033B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.032B 0.00
Aprea Therapeutics (APRE) United States $0.032B 0.00
IN8bio (INAB) United States $0.031B 0.00
MiNK Therapeutics (INKT) United States $0.031B 0.00
Theratechnologies (THTX) Canada $0.031B 0.00
Lexaria Bioscience (LEXX) Canada $0.030B 0.00
Pluri (PLUR) Israel $0.030B 0.00
Prenetics Global (PRE) Cayman Islands $0.029B 0.00
Femasys (FEMY) United States $0.029B 0.00
Evogene (EVGN) Israel $0.029B 0.00
Spruce Biosciences (SPRB) United States $0.029B 0.00
Forte Biosciences (FBRX) United States $0.027B 0.00
NKGen Biotech (NKGN) United States $0.026B 0.00
Eyenovia (EYEN) United States $0.026B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.026B 0.00
Aileron Therapeutics (ALRN) United States $0.026B 0.00
UNITY Biotechnology (UBX) United States $0.026B 0.00
Sensei Biotherapeutics (SNSE) United States $0.025B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.023B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.023B 0.00
Biora Therapeutics (BIOR) United States $0.022B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.022B 0.00
Evaxion Biotech (EVAX) Denmark $0.021B 0.00
Synlogic (SYBX) United States $0.021B 0.00
Lumos Pharma (LUMO) United States $0.020B 0.00
Vincerx Pharma (VINC) United States $0.020B 0.00
Aptose Biosciences (APTO) Canada $0.020B 0.00
KALA BIO (KALA) United States $0.019B 0.00
RenovoRx (RNXT) United States $0.019B 0.00
Galecto (GLTO) Denmark $0.019B 0.00
Orgenesis (ORGS) United States $0.017B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.017B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.016B 0.00
Aytu BioPharma (AYTU) United States $0.016B 0.00
Talis Biomedical (TLIS) United States $0.015B 0.00
Cocrystal Pharma (COCP) United States $0.015B 0.00
VBI Vaccines (VBIV) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Senti Biosciences (SNTI) United States $0.014B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.013B 0.00
Imunon (IMNN) United States $0.013B 0.00
Monopar Therapeutics (MNPR) United States $0.013B 0.00
Benitec Biopharma (BNTC) United States $0.012B 0.00
Genetic Technologies (GENE) Australia $0.012B 0.00
ABVC BioPharma (ABVC) United States $0.012B 0.00
Eterna Therapeutics (ERNA) United States $0.012B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.012B 0.00
Organovo Holdings (ONVO) United States $0.012B 0.00
Telesis Bio (TBIO) United States $0.011B 0.00
Purple Biotech (PPBT) Israel $0.010B 0.00
Elevai Labs (ELAB) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Galera Therapeutics (GRTX) United States $0.009B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.009B 0.00
Adial Pharmaceuticals (ADIL) United States $0.009B 0.00
Biorestorative Therapies (BRTX) United States $0.009B 0.00
Longeveron (LGVN) United States $0.009B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.009B 0.00
Virios Therapeutics (VIRI) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
TFF Pharmaceuticals (TFFP) United States $0.008B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.008B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Pasithea Therapeutics (KTTA) United States $0.008B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.007B 0.00
Chemomab Therapeutics (CMMB) Israel $0.007B 0.00
Trevena (TRVN) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Enveric Biosciences (ENVB) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.006B 0.00
First Wave BioPharma (FWBI) United States $0.006B 0.00
Psyence Biomedical (PBM) United States $0.006B 0.00
Atrinsic (PTIX) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Vaccinex (VCNX) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Exicure (XCUR) United States $0.005B 0.38
Seelos Therapeutics (SEEL) United States $0.005B 0.00
Kineta (KA) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
Soligenix (SNGX) United States $0.005B 0.00
PaxMedica (PXMD) United States $0.005B 0.00
Novogen (KZIA) Australia $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
Artelo Biosciences (ARTL) United States $0.005B 0.00
GENPREX (GNPX) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Kintara Therapeutics (KTRA) United States $0.004B 0.00
Biophytis SA (BPTS) France $0.004B 0.00
Cingulate (CING) United States $0.004B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.004B 0.00
TRACON Pharmaceuticals (TCON) United States $0.004B 0.00
NexImmune (NEXI) United States $0.004B 0.00
Mustang Bio (MBIO) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
ThermoGenesis Holdings (THMO) United States $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Invo BioScience (INVO) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
GRI Bio (GRI) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Allarity Therapeutics (ALLR) United States $0.001B 0.00
Aptevo Therapeutics (APVO) United States $0.000B 0.00
Sinovac Biotech (SVA) China $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00